vs
Digimarc CORP（DMRC）与Monte Rosa Therapeutics, Inc.（GLUE）财务数据对比。点击上方公司名可切换其他公司
Monte Rosa Therapeutics, Inc.的季度营收约是Digimarc CORP的1.4倍（$12.8M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -212.1%，领先164.9%），Monte Rosa Therapeutics, Inc.同比增速更快（38.5% vs 2.9%），Monte Rosa Therapeutics, Inc.自由现金流更多（$99.8M vs $895.0K）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
Monte Rosa Therapeutics是一家临床阶段生物技术企业，专注于研发靶向分子胶降解剂疗法，管线覆盖肿瘤、罕见遗传病及免疫疾病领域的未满足医疗需求，通过自主研发与行业合作推进创新疗法惠及全球患者。
DMRC vs GLUE — 直观对比
营收规模更大
GLUE
是对方的1.4倍
$8.9M
营收增速更快
GLUE
高出35.7%
2.9%
净利率更高
DMRC
高出164.9%
-212.1%
自由现金流更多
GLUE
多$98.9M
$895.0K
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $12.8M |
| 净利润 | $-4.2M | $-27.1M |
| 毛利率 | 63.5% | — |
| 营业利润率 | -48.2% | -258.3% |
| 净利率 | -47.2% | -212.1% |
| 营收同比 | 2.9% | 38.5% |
| 净利润同比 | 51.4% | -13.5% |
| 每股收益（稀释后） | $-0.18 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCGLUE
| Q4 25 | $8.9M | — | ||
| Q3 25 | $7.6M | $12.8M | ||
| Q2 25 | $8.0M | $23.2M | ||
| Q1 25 | $9.4M | $84.9M | ||
| Q4 24 | $8.7M | $60.6M | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $10.4M | — | ||
| Q1 24 | $9.9M | — |
净利润DMRCGLUE
| Q4 25 | $-4.2M | — | ||
| Q3 25 | $-8.2M | $-27.1M | ||
| Q2 25 | $-8.2M | $-12.3M | ||
| Q1 25 | $-11.7M | $46.9M | ||
| Q4 24 | $-8.6M | $13.4M | ||
| Q3 24 | $-10.8M | — | ||
| Q2 24 | $-9.3M | — | ||
| Q1 24 | $-10.3M | — |
毛利率DMRCGLUE
| Q4 25 | 63.5% | — | ||
| Q3 25 | 58.3% | — | ||
| Q2 25 | 58.8% | — | ||
| Q1 25 | 65.0% | — | ||
| Q4 24 | 60.8% | — | ||
| Q3 24 | 62.4% | — | ||
| Q2 24 | 66.1% | — | ||
| Q1 24 | 62.5% | — |
营业利润率DMRCGLUE
| Q4 25 | -48.2% | — | ||
| Q3 25 | -109.7% | -258.3% | ||
| Q2 25 | -105.2% | -67.1% | ||
| Q1 25 | -128.9% | 51.9% | ||
| Q4 24 | -105.1% | 21.4% | ||
| Q3 24 | -120.4% | — | ||
| Q2 24 | -96.2% | — | ||
| Q1 24 | -109.2% | — |
净利率DMRCGLUE
| Q4 25 | -47.2% | — | ||
| Q3 25 | -106.9% | -212.1% | ||
| Q2 25 | -102.6% | -53.0% | ||
| Q1 25 | -125.2% | 55.2% | ||
| Q4 24 | -99.9% | 22.2% | ||
| Q3 24 | -113.9% | — | ||
| Q2 24 | -89.3% | — | ||
| Q1 24 | -104.0% | — |
每股收益（稀释后）DMRCGLUE
| Q4 25 | $-0.18 | — | ||
| Q3 25 | $-0.38 | — | ||
| Q2 25 | $-0.38 | — | ||
| Q1 25 | $-0.55 | — | ||
| Q4 24 | $-0.40 | — | ||
| Q3 24 | $-0.50 | — | ||
| Q2 24 | $-0.43 | — | ||
| Q1 24 | $-0.50 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $208.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $245.8M |
| 总资产 | $53.0M | $459.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCGLUE
| Q4 25 | $12.9M | — | ||
| Q3 25 | $12.6M | $208.3M | ||
| Q2 25 | $16.1M | $69.4M | ||
| Q1 25 | $21.6M | $78.5M | ||
| Q4 24 | $28.7M | $224.3M | ||
| Q3 24 | $33.7M | — | ||
| Q2 24 | $41.5M | — | ||
| Q1 24 | $48.9M | — |
股东权益DMRCGLUE
| Q4 25 | $40.2M | — | ||
| Q3 25 | $41.4M | $245.8M | ||
| Q2 25 | $46.5M | $268.1M | ||
| Q1 25 | $50.0M | $275.2M | ||
| Q4 24 | $61.4M | $222.9M | ||
| Q3 24 | $70.2M | — | ||
| Q2 24 | $77.2M | — | ||
| Q1 24 | $84.5M | — |
总资产DMRCGLUE
| Q4 25 | $53.0M | — | ||
| Q3 25 | $55.4M | $459.8M | ||
| Q2 25 | $60.7M | $359.6M | ||
| Q1 25 | $66.5M | $393.2M | ||
| Q4 24 | $75.8M | $438.7M | ||
| Q3 24 | $85.0M | — | ||
| Q2 24 | $93.4M | — | ||
| Q1 24 | $99.7M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $100.4M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $99.8M |
| 自由现金流率自由现金流/营收 | 10.0% | 781.5% |
| 资本支出强度资本支出/营收 | 1.1% | 5.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $145.0M |
8季度趋势，按日历期对齐
经营现金流DMRCGLUE
| Q4 25 | $991.0K | — | ||
| Q3 25 | $-2.6M | $100.4M | ||
| Q2 25 | $-4.7M | $-34.7M | ||
| Q1 25 | $-5.5M | $-45.5M | ||
| Q4 24 | $-4.2M | $128.9M | ||
| Q3 24 | $-7.1M | — | ||
| Q2 24 | $-6.8M | — | ||
| Q1 24 | $-8.4M | — |
自由现金流DMRCGLUE
| Q4 25 | $895.0K | — | ||
| Q3 25 | $-2.8M | $99.8M | ||
| Q2 25 | $-4.9M | $-36.4M | ||
| Q1 25 | $-5.5M | $-47.1M | ||
| Q4 24 | $-4.2M | $128.7M | ||
| Q3 24 | $-7.2M | — | ||
| Q2 24 | $-6.9M | — | ||
| Q1 24 | $-8.5M | — |
自由现金流率DMRCGLUE
| Q4 25 | 10.0% | — | ||
| Q3 25 | -36.9% | 781.5% | ||
| Q2 25 | -61.0% | -157.0% | ||
| Q1 25 | -59.1% | -55.4% | ||
| Q4 24 | -49.1% | 212.3% | ||
| Q3 24 | -75.7% | — | ||
| Q2 24 | -66.1% | — | ||
| Q1 24 | -85.8% | — |
资本支出强度DMRCGLUE
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.9% | 5.1% | ||
| Q2 25 | 2.5% | 7.3% | ||
| Q1 25 | 0.6% | 1.9% | ||
| Q4 24 | 0.2% | 0.3% | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 1.1% | — |
现金转化率DMRCGLUE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.97× | ||
| Q4 24 | — | 9.59× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
GLUE
暂无分部数据
